Title:Comparison of Clinical Characteristics, Laboratory Findings and Imaging Manifestations of COVID-19 in Sulfur Mustard-exposed Survivors and Others: a Case-control Study
Volume: 16
Issue: 3
Author(s): Reza Hosseiniara, Seyed Mohammad Javad Hosseini , Seyed Ali Mirhosseini , Jennifer Swann , Majid Mirzaei Nodoushan , Mojtaba Sharti, Hamidreza Ebrahimi Nezhad, Hassan Amanpour , Maryam Shahriari , Gholamreza Farnoosh , Mohsen Abbasi Farajzadeh and Alireza Jalali Farahani*
Affiliation:
- Atherosclerosis Research Center, Baqiyatallah University of Medical Sciences, Tehran,Iran
Keywords:
COVID-19, SARS-CoV-2, sulfur mustard, pathogenesis, WHO, pneumonia.
Abstract:
Objective: The objective of this study is to determine if previous exposure to sulfur mustard
(SM) gas increases the pathogenesis of COVID-19 by comparing clinical characteristics, laboratory
findings, and imaging data between SM-exposed survivors and other patients with COVID-19.
Methods: This case-control study was conducted in Baqiyatallah hospital, Tehran, Iran, from 26th Feb
– 26th March 2020. The case group composed of 60 SM-exposed survivors infected with COVID-19,
and the control group was composed of 60 patients with COVID-19. Groups were matched for demographic
(including age and gender) and comorbidity variables except for lung disease which was higher
in the case group. The clinical characteristics, laboratory findings, and imaging manifestations, as
well as outcomes, were compared between the two groups.
Results: While the majority of patients in the case and control groups had at least one comorbidity like
diabetes, hypertension, or heart disease, only lung disease was significantly higher in the case than in
the control group (P=0.001). Patients in both groups displayed a variety of symptoms on arrival. Only
chest pain was significantly more frequent in case patients than those in the control group. The levels
of Neutrophils, ESR, BS, AST, LDH, and CRP in both groups were higher, and Na levels were lower
than the normal range. Neutrophils were significantly higher in the case than in the control group
(p=0.02). The BUN level was significantly lower in the control than in the case group (p=0.04). Other
laboratory findings were within their normal ranges and similar in both groups. Significantly more patients
in the case group showed early-stage opacities than those in the control group (p=.03). There
were no significant differences in treatment or outcomes between the two groups.
Conclusion: Most clinical characteristics, outcomes, and laboratory findings of COVID-19 in SMexposed
survivors, were similar to those in the non-exposed. While these findings suggest that sulfur
mustard gas exposure does not significantly affect the prognosis of the disease, the limitations and
sample size of the current study may warrant additional investigations.
